30 minutes ago
Children receiving 50 nmol PVX108 increased their tolerated peanut dose 2.4-fold, with no treatment-related anaphylaxis in the phase 2 trial.
1 hour ago
Christopher Kramer, MD, discusses his substudy of SUMMIT, which utilized CMR imaging to evaluate further heart health metrics versus standard imaging.
2 hours ago
Silent mucus plugs may flag patients with COPD at greater risk of exacerbations and death, though how to manage them remains unclear.
3 hours ago
In VITESSE, peanut-specific IgG4 rose about 5-fold in children aged 4 to 7 years, David Fleischer, MD, told HCPLive at ACAAI 2026.
4 hours ago
Leslee Shaw, PhD, discusses her analysis of the DECIDE registry, indicating the possible connection between AI-CPA and superior lipid management.